Rutosides for treatment of post-thrombotic syndrome

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Morling, Joanne R ^a   Yeoh, Su Ern ^b   Kolbach, Dinanda N ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RUTOSIDE; PLANT EXTRACT;

CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DRUG SAFETY; HUMAN; LEG ULCER; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; AESCULUS; CHEMISTRY; COMPLICATION; COMPRESSION STOCKING; META ANALYSIS; PHYTOTHERAPY; POSTTHROMBOTIC SYNDROME; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); VEIN THROMBOSIS; WATCHFUL WAITING;

AESCULUS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; POSTTHROMBOTIC SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RUTIN; STOCKINGS, COMPRESSION; VENOUS THROMBOSIS; WATCHFUL WAITING;

EID: 84964693251     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005625.pub3     Document Type: Review

References (29)

1. De Jongste AB, Jonker JJ, Huisman MV, Ten Cate JW, Azar AJ. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome. Thrombosis and Haemostasis 1989;62(3):826-9.
2. De Jongste AB, Jonker JJC, Huisman MV, Ten Cate JW, Azar AJ. A double-blind trial on the short-term efficacy of HR in patients with the post-thrombotic syndrome. Phlebology 1990;5 Suppl 1:21-2.
3. Monreal M, Callejas JM, Martorell A, Lisbona C, Lerma R. A prospective study of the long-term efficacy of two different venoactive drugs in patients with post-thrombotic syndrome. Phlebology 1994;9:37-40.
4. Prandoni P. Elastic stockings, hydroxyethylrutosides or both for the treatment of post-thrombotic syndrome. Thrombosis and Haemostasis 2005;93(1):183-5.
5. Cospite M, Amato C, Milio G, Scrivano V. Changes of venous haemodynamics in subjects with post-thrombotic syndrome, treated with high doses of diosmine in association with other bioflavonoids. What is New in Angiology? Trends and Controversies. Zuckschwerdt W, 1986.
6. De Jongste AB, Ten Cate JW, Huisman MV. The effectiveness of 0-(beta-hydroxyethyl)-rutosides (HR) in the post-thrombotic syndrome (PTS). Phlebology'85. John Libbey and Co. Ltd, 1986:837-9.
7. Diebschlag W, Nocker W, Lehmacher W, Rehn D. A clinical comparison of two doses of 0-(beta-Hydroxyethyl)-rutosides (oxerutins) in patients with chronic venous insufficiency. Journal of Pharmaceutical Medicine 1994;4(1):7-14.
8. Incandela L, Belcaro G, Renton S, DeSanctis MT, Cesarone MR, Bavera, et al. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. Journal of Cardiovascular Pharmacology and Therapeutics 2002;7 Suppl 1:S7-10.
9. Nill HJ, Fischer H. Comparative investigations concerning the effect of extract of horse chestnut upon the pressure-volume-diagram of patients with venous disorders [Vergleichende Untersuchungen zur Beeinflussung des Druck-Volumen-Diagramms durch Roßkastanienextrakt bei Venenkranken]. Arztliche Forschung 1970;24(5):141-3.
10. Rose SS. A report on the use of an hydroxyethylrutoside in symptoms due to venous back pressure and allied conditions in the lower limbs. British Journal of Clinical Practice 1970;24(4):161-4.
11. Bombardelli E, Morazzoni P, Griffini A. Aesculus hippocastanum L. Fitoterapia 1996;67(6):483-511.
12. Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, et al. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology 2005;56(2):165-72.
13. Cohen JM, Akl EA, Kahn SR. Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials. Chest 2012;141(2):308-20.
14. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Archiv der Pharmazie 1995;328(10):720-4.
15. Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittel-Forschung 1994;44(1):25-35.
16. Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at www.cochrane-handbook.org.
17. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, Subcommittee on control of anticoagulation of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. Journal of Thrombosis and Haemostasis 2009;7(5):879-83.
18. Lorenz D, Marek ML. Das therapeutische wirksame Prinzip der Rosskastanie (Aesculus hippocastanum). Arzneimittel-Forschung/Drug Research 1960;10:263-72.
19. Morling JR, Yeo SE, Kolbach DN. Rutosides for the prevention of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD005626.pub2]
20. Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. International Journal of Microcirculation: Clinical and Experimental 1987;5(4):311-20.
21. Partsch H. Compression therapy of the legs. A review. Journal of Dermatologic Surgery and Oncology 1991;17(10):799-805.
22. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD003230.pub4]
23. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine 1996;125(1):1-7.
24. Sarin S, Andaz A, Shields DA, Scurr JH, Coleridge Smith PD. Neutrophil activation in venous disease. Journal of Vascular Surgery 1993;17:444.
25. Schrader E, Schwankl W, Sieder C, Christoffel V. Comparison of the bioavailability of beta-aescin after single oral administration of two different drug formulations containing an extract of horse-chestnut seeds [Vergleichende Untersuchung zur Bioverfügbarkeit von ß-Aescin nach oraler Einmalverabreichung zweier Rosskastaniensamenextrakt enthaltender, galenisch unterschiedlicher Darreichungsformen]. Pharmazie 1995;50(9):623-7.
26. Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. BMJ 1988;296(6638):1693-5.
27. Villalta S, Bagatella P, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis 1994;24:158a.
28. Kolbach DN, Prins MH. Rutosides for treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005625]
29. Morling JR, Yeoh SE, Kolbach DN. Rutosides for treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD005625.pub2]